English

TNFR2

TNFR2 Molekülinformation

Englischer Name	Tumor necrosis factor receptor superfamily member 1B	Anzahl der inverkehr gebrachten Arzneimittel	1
Anzahl der klinischen Arzneimittel	8	Target-Alias	TNFR-II，TNFR80，TNF-RII，p80 TNF-alpha receptor，p75，Tumor necrosis factor receptor 2，Etanercept，TBP-2，Tumor necrosis factor receptor type II，TBPII，CD120b，TNF-R-II，CD120b Antigen，Tumor Necrosis Factor Beta Receptor，Soluble TNFR1B Variant 1，Tumor Necrosis Factor Binding Protein 2，TNFBR，TNF Receptor Superfamily Member 1B，TNFR2，P75 TNF Receptor，P75TNFR，TNFR1B，Tumor Necrosis Factor Receptor Superfamily， Member 1B，TNF-R75，TNF-R2
Höchste Forschungs- und Entwicklungsphase	Approved

Englischer Name	Tumor necrosis factor receptor superfamily member 1B
Target-Alias	TNFR-II，TNFR80，TNF-RII，p80 TNF-alpha receptor，p75，Tumor necrosis factor receptor 2，Etanercept，TBP-2，Tumor necrosis factor receptor type II，TBPII，CD120b，TNF-R-II，CD120b Antigen，Tumor Necrosis Factor Beta Receptor，Soluble TNFR1B Variant 1，Tumor Necrosis Factor Binding Protein 2，TNFBR，TNF Receptor Superfamily Member 1B，TNFR2，P75 TNF Receptor，P75TNFR，TNFR1B，Tumor Necrosis Factor Receptor Superfamily， Member 1B，TNF-R75，TNF-R2
Anzahl der inverkehr gebrachten Arzneimittel	1
Anzahl der klinischen Arzneimittel	8
Höchste Forschungs- und Entwicklungsphase	Approved

TNFR2 Produktliste

Attribut
Protein (10)
Produktbibliothek
Online (10)
Spezies
Human (4)Cynomolgus / Rhesus macaque (1)Mouse (3)Mouse & Human (1)Human & Mouse (1)
Etikett
His Tag (5)His Tag & Avi Tag (2)Fc Tag (2)Fc Tag & Avi Tag (1)
Marker
Unconjugated (7)Biotin-labeled (3)

Produktnummer	Spezies	Expressionssystem	Produktbeschreibung	Vorbestellen/Bestellen
HOT TN2-H5227	Human	HEK293	Human TNFR2 / CD120b / TNFRSF1B Protein, His Tag, low endotoxin (MALS verified)	In den Warenkorb legen
HOT TN2-H5253	Human	HEK293	Human TNFR2 / CD120b / TNFRSF1B Protein, Fc Tag (MALS verified)	In den Warenkorb legen
HOT TN2-H82E3	Human	HEK293	Biotinylated Human TNFR2 / CD120b / TNFRSF1B Protein, His,Avitag™ (MALS verified)	In den Warenkorb legen
HOT TN2-C52H7	Cynomolgus / Rhesus macaque	HEK293	Cynomolgus / Rhesus macaque TNFR2 / CD120b / TNFRSF1B Protein, His Tag	In den Warenkorb legen
TN2-H82F3	Human	HEK293	Biotinylated Human TNFR2 / CD120b / TNFRSF1B Protein, Fc,Avitag™ (MALS verified)	In den Warenkorb legen
TN2-M5254	Mouse	HEK293	Mouse TNFR2 / CD120b / TNFRSF1B Protein, Fc Tag (MALS verified)	In den Warenkorb legen
TN2-M52H8	Mouse	HEK293	Mouse TNFR2 / CD120b / TNFRSF1B Protein, His Tag	In den Warenkorb legen
TN2-M82E3	Mouse	HEK293	Biotinylated Mouse TNFR2 / CD120b / TNFRSF1B Protein, His,Avitag™ (MALS verified)	In den Warenkorb legen
TN2-H52H3	Human & Mouse	HEK293	Human & Mouse TNFR2 / CD120b / TNFRSF1B Protein, His Tag, low endotoxin (MALS verified)	In den Warenkorb legen
TN2-M52H3	Mouse & Human	HEK293	Mouse & Human TNFR2 / CD120b / TNFRSF1B Protein, His Tag, low endotoxin (MALS verified)	In den Warenkorb legen

Gesamtmenge10

Produktanfrage

TNFR2 Molekülhintergrund

TNFR2 (tumor necrosis factor receptor superfamily member 1B) is a receptor with high affinity for TNFSF2/TNF-alpha. It has a much lower affinity for homotrimeric TNFSF1/lymphotoxin-alpha. The TRAF1/TRAF2 complex recruits the apoptotic suppressors BIRC2 and BIRC3 to TNFRSF1B/TNFR2. TNFR2 mediates most of the metabolic effects of TNF-alpha.

TNFR2 Molekülalias

TNFRSF1B,CD120b,TBPII,TNF-R-II,TNF-R75,TNFBR,TNFR1B,TNFR2,TNFR80,p75,p75TNFR

Klinische Arzneimittelinformation

Englischer Name	Forschungscode	Forschungsphase	Firma	Indikationen	Klinische Studie
LBL-019	LBL-019	Phase 2 Clinical	Nanjing Leadsbiolabs Co Ltd	Neoplasms	Details
BI-1910	BI-1910	Phase 2 Clinical	Bioinvent International Ab	Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Solid tumours	Details
BITR-2101	BITR-2101; BIR-2101; BITT2101; BITT-2101	Phase 1 Clinical	Boston Immune Technologies & Therapeutics	Infections; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Neoplasms	Details
TRB-061	TRB-061	Phase 1 Clinical	Trex Bio Inc	Colitis; Dermatitis; Dermatitis, Atopic	Details
NBL-020		Phase 1 Clinical	Shanghai Xinshi Biological Medicine Co Ltd	Neoplasms; Solid tumours	Details
BC-011	BC-011	Phase 1 Clinical	Dragonboat Biopharmaceutical	Solid tumours	Details
SIM1811-03	SIM1811-03; SIM0235; SIM-235	Phase 1 Clinical	Jiangsu Simcere Pharmaceutical Co Ltd	Lymphoma, T-Cell, Cutaneous; Neoplasms; Solid tumours	Details
Emunkitug	HFB-2003; HFB-200301	Phase 1 Clinical	HiFiBiO Therapeutics	Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Germinoma; Melanoma; Mesothelioma; Neoplasm Metastasis; Neoplasms; Sarcoma; Skin Melanoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Testicular Neoplasms; Uterine Cervical Neoplasms	Details

Inverkehr gebrachte Arzneimittelinformation

Englischer Name	Forschungscode	Forschungsphase	Firma	Frühestes Markenname	Frühestes Genehmigungsland	Früheste Indikation	Früheste Genehmigungsgesellschaft	Früheste Genehmigungsdatum	Indikationen	Klinische Studie
Recombinant human type II tumor necrosis factor receptor-antibody fusion protein(Hisun Biological)		Approved	Hisun Biopharmaceutical Co Ltd		Mainland China	Spondylitis, Ankylosing; Psoriasis; Arthritis, Rheumatoid	Hisun Biopharmaceutical Co Ltd	2015-04-09	Arthritis, Rheumatoid; Psoriasis; Spondylitis, Ankylosing	Details

Molekülinformation
Produktliste
Inverkehr gebrachte Arzneimittelinformation
Klinische Arzneimittelinformation